Results 71 to 80 of about 29,009 (218)

Risk stratification and anal cancer screening in immunocompetent women with genital HPV: Value of multicentric HSIL and performance of HPV‐based screening

International Journal of Cancer, EarlyView.
What's New? Anal squamous cell carcinoma (ASCC) incidence is increasing, with most cases occurring in immunocompetent women. ASCC risk is linked in particular to genital human papillomavirus (HPV) infection and HPV‐associated high‐grade squamous intraepithelial lesions (HSILs).
Isabel Matas, Aureli Torné, Adela Saco, Cristina Martí, Ada Cardiel, Natalia Rakislova, Lorena Marimon, Ariel Glickman, Ingrid Victoria, Silvia Alós, Jesús Lopez‐Diaz, Pere Fusté, Jaume Ordi, Marta del Pino   +13 more
wiley   +1 more source

Attenuated Effects of Topical Empagliflozin on Imiquimod-induced Model of Psoriasis in Mice

Journal of Tropical Life Science
Empagliflozin is a sodium-glucose cotransporter inhibitor (SGLT2) that drops blood glucose levels by inhibiting glucose reabsorption and encouraging glucose excretion.
Alaa H. Abbas, Zahraa H Abbas, Hayder Ridha Salman, Hayder E Jabar, Abdulkareem H. Abd   +4 more
doaj   +1 more source

Dextran sodium sulfate confounds causal role of periodontitis in inflammatory bowel disease

Journal of Periodontology, EarlyView.
Abstract Background Emerging evidence supports a bidirectional link between periodontitis and inflammatory bowel disease (IBD). To investigate this relationship, experimental models commonly use dextran sodium sulfate (DSS) to induce colitis. However, DSS is presumed to selectively affect the colon, and its potential off‐target effects on the oral ...
Himanshi Tanwar, Jeba Mercy Gnanasekaran, Niyant Ganesh, Cindy Zhou, Amy Plotkin, Giacomo Baima, Massimo Costalonga, Fenfen Zhou, Hanping Feng, Priyam Jani, Jean‐Pierre Raufman, Vivek Thumbigere‐Math   +11 more
wiley   +1 more source

Imiquimod-induced bullous pemphigoid: A case report

SAGE Open Medical Case Reports, 2023
A 72-year-old man treated with 3.5% imiquimod cream for scalp actinic keratoses developed the usual crusted and erosive reaction but developed bullae on the scalp, as well as the limbs and torso after several weeks into treatment.
Heidi Oi-Yee Li, Michael Aw, Steven J Glassman   +2 more
doaj   +1 more source

Overview on topical 5-ALA photodynamic therapy use for non melanoma skin cancers [PDF]

, 2014
Ultraviolet radiation (UV) contributes to a variety of skin diseases including inflammation, degenerative aging, and cancer. Historically, humans have been exposed to UV radiation mainly through occupational exposure; recreational UV exposure, however ...
Bianchini, Daniela, Calvieri, Stefano, Cantisani, Carmen, Cantoresi, Franca, Faina, Valentina, Fazia, Gilda, Frascani, Federica, Paolino, Giovanni   +7 more
core   +3 more sources

Involvement of µ-opioid Receptors and κ-opioid Receptors in Itch-related Scratching Behaviour of Imiquimod-induced Psoriasis-like Dermatitis in Mice

Acta Dermato-Venereologica, 2017
The pathogenesis of psoriatic itch is poorly understood. The aim of this study was to investigate the involvement of opioid receptors in scratching behaviour of imiquimod-induced psoriasis-like dermatitis model mice.
Nobuaki Takahashi, Mitsutoshi Tominaga, Ryohei Kosaka, Yayoi Kamata, Yoshie Umehara, Hironori Matsuda, Azumi Sakaguchi, Hideoki Ogawa, Kenji Takamori   +8 more
doaj   +1 more source

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream

Journal of Translational Medicine, 2007
Background The objective of this study was to identify the molecular processes responsible for the anti-lesional activity of imiquimod in subjects with actinic keratosis using global gene expression profiling.
Raghavan Shalini, Jin Jizhong, Bulbulian Barbara J, Miller Richard L, Anders Makala, Storey Leslie, Torres Abel, Lee James, Slade Herbert B, Birmachu Woubalem   +9 more
doaj   +1 more source

Disease-Independent Skin Recruitment and Activation of Plasmacytoid Predendritic Cells Following Imiquimod Treatment [PDF]

, 2017
Background: Imiquimod, an immune response modifier that is used topically to treat different types of skin cancer, induces the production of proinflammatory cytokines that stimulate an antitumor immune response.
Beyeler, Mirjam, Burg, Günter, Conrad, Curdin, Dummer, Reinhard, Gilliet, Michel, Laine, Elisabeth, Urosevic, Mirjana   +6 more
core  

Topical immunotherapy for the treatment of periocular basal cell carcinoma [PDF]

, 2009
Os autores descrevem um paciente com carcinoma basocelular nodular em canto medial tratado com imiquimode creme 5%. A avaliação patológica de uma biópsia incisional realizada 12 semanas após o tratamento revelou a total resolução da lesão.
CARNEIRO, Rachel Camargo, MACEDO, Erick Marcet Santiago de, MATAYOSHI, Suzana   +2 more
core   +2 more sources

Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review

JEADV Clinical Practice, EarlyView.
ABSTRACT In recent years, innovative topical medications with novel mechanisms of action have emerged to treat common dermatologic conditions such as acne, atopic dermatitis, vitiligo, and actinic keratoses. These molecularly targeted therapies offer improved safety and tolerability compared to traditional options like corticosteroids.
Mary Dyson, Kara Hurley, Hannah Chaudhury, Lara Shehadeh, Cameron West   +4 more
wiley   +1 more source